Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services

NCT06128304

RecruitingNA

Sponsor: University of California, San Diego

Conditions: HIV, Cervical Cancer

Interventions: Core Implementation strategies, Core+ Enhanced Implementation Strategies

Countries: United States, Nigeria

While there has been a significant increase in the uptake of antiretroviral therapy among women living with HIV (WLHIV) in many low- and-middle income countries (LMICs), the coverage of cervical cancer screening and treatment (CCST) among WLHIV remains low. This study aims to leverage the available infrastructure for HIV care and treatment programs in Nigeria to integrate cervical cancer screening and treatment and conduct a cluster randomized, hybrid type III trial design to assess the comparative effectiveness of a Core set of implementation strategies versus a Core+ (enhanced) set of implementation strategies to implement cervical cancer screening, onsite treatment, referral and referral completion, treatment, and retention in care among WLHIV. The overarching goal is to improve the health and life expectancy of WLHIV with co-occurring cervical cancer.

Eligibility overview

Sex: FEMALE

Age: 25 Years to 64 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Women living with HIV

Exclusion Criteria:

\-
Locations (2)
  • La Jolla, California, United States
  • Enugu, Enugu State, Nigeria